OSAHS:2型糖尿病的另一独立危险因素
OSAHS: Another Independent Risk Factor of Type 2 Diabetes
DOI: 10.12677/ACM.2017.71006, PDF, HTML, XML, 下载: 2,362  浏览: 5,646  科研立项经费支持
作者: 石庆柳:贵州医科大学,贵州 贵阳;叶贤伟, 李 丹, 赵 丹, 赵远琴, 彭春红, 张湘燕:贵州省人们医院,贵州省呼吸疾病研究所,贵州 贵阳
关键词: 阻塞性睡眠呼吸暂停低通气综合征2型糖尿病胰岛素抵抗Obstructive Sleep Apnoea-Hypopnea Syndrome Type 2 Diabetes Insulin Resistance
摘要: OSAHS是一种常见的睡眠呼吸疾患,可导致多系统并发症,增加心血管疾病发病率及死亡率,严重影响患者健康,甚至引起交通安全隐患,近年来成为呼吸医学界关注的新焦点。大量研究证明OSAHS是2型糖尿病、胰岛素抵抗的独立危险因素。合并OSAHS的2型糖尿病患者血糖控制往往疗效欠佳。有效的持续正压通气治疗(CPAP)在一定程度上能够使OSAHS合并糖代谢紊乱的患者获益。故,糖尿病或糖尿病高风险患者应常规行OSAHS筛查,以便早期诊断、早期干预及个体化治疗。
Abstract: Obstructive Sleep Apnoea-Hypopnea Syndrome (OSAHS) is a highly prevalent respiratory disorder which can lead to multiple complications and contribute to high morbidity and mortality of cardi-ovascular disease and high risk of traffic accident. It has aggressively affected the public health and aroused increasing concern in respiratory medicine recently. Current evidence supports an independent association between OSAHS and insulin resistance, glucose intolerance and the risk of type 2 diabetes, independent of obesity. Additionally, OSAHS often leads to worse glycaemic control in diabetics. Efficient CPAP therapy can benefit OSAHS patients with impaired glucose metabolism. In conclusion, diabetics or patients with high risk of diabetes should be routinely screened for early diagnosis, early intervention and individualized treatment for OSAHS.
文章引用:石庆柳, 叶贤伟, 李丹, 赵丹, 赵远琴, 彭春红, 张湘燕. OSAHS:2型糖尿病的另一独立危险因素[J]. 临床医学进展, 2017, 7(1): 30-39. https://doi.org/10.12677/ACM.2017.71006

参考文献

[1] Morgenstern, M., Wang, J., Beatty, N., Batemarco, T., Sica, A.L. and Greenberg, H. (2014) Obstructive Sleep Apnea: An Unexpected Cause of Insulin Resistance and Diabetes. Diabetes Mellitus. Associated Conditions Endocrinology and Metabolism Clinics of North America, 43, 187-204.
[2] Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S. and Badr, S. (1993) The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults. The New England Journal of Medicine, 328, 1230-1235.
https://doi.org/10.1056/NEJM199304293281704
[3] 魏永祥, 付春华, 杨非衡, 肖明明, 林莎. 北京市朝阳区成人打鼾及阻塞性睡眠呼吸暂停低通气综合征流行病学调查[J]. 中国医药导报, 2013, 10(27): 108-111.
[4] Young, T., Peppard, P.E. and Taheri, S. (2005) Excess Weight and Sleep-Disordered Breathing. Journal of Applied Physiology, 99, 1592-1599.
[5] Rajan, P. and Greenberg, H. (2015) Obstructive Sleep Apnea as a Risk Factor for Type 2 Diabetes Mellitus. Nature and Science of Sleep, 7, 113-125.
[6] Wang, X., Bi, Y., Zhang, Q. and Pan, F. (2013) Obstructive Sleep Apnoea and the Risk of Type 2 Diabetes: A Meta-Analysis of Prospective Cohort Studies. Respirology, 18, 140-146.
https://doi.org/10.1111/j.1440-1843.2012.02267.x
[7] Araújo, L.S., Fernandes, J.F.R., Klein, M.R.S.T. and Sanjuliani, A.F. (2015) Obstructive Sleep Apnea Is Independently Associated with Inflammation and Insulin Resistance, But Not with Blood Pressure, Plasma Catecholamines, and Endothelial Function in Obese Subjects. Nutrition, 31, 1351-1357.
[8] Borel, A., Monneret, D., Tamisier, R., et al. (2013) The Severity of Nocturnal Hypoxia But Not Abdominal Adiposity Is Associated with Insulin Resistance in Non-Obese Men with Sleep Apnea. PLoS ONE, 8, e71000.
https://doi.org/10.1371/journal.pone.0071000
[9] Seicean, S., Kirchner, H.L., Gottlieb, D.J., et al. (2008) Sleep-Disordered Breathing and Impaired Glucose Metabolism in Normal-Weight and Overweight/Obese Individuals: The Sleep Heart Health Study. Diabetes Care, 31, 1001-1006.
https://doi.org/10.2337/dc07-2003
[10] Punjabi, N.M. and Beamer, B.A. (2009) Alterations in Glucose Disposal in Sleep-Disordered Breathing. American Journal of Respiratory and Critical Care Medicine, 179, 235-240.
https://doi.org/10.1164/rccm.200809-1392OC
[11] Sharafkhaneh, A., Richardson, P. and Hirshkowitz, M. (2004) Sleep Apnea in a High Risk Population: A Study of Veterans Health Administration Beneficiaries. Sleep Medicine, 5, 345-350.
[12] Aronsohn, R.S., Whitmore, H., Van Cauter, E. and Tasali, E. (2010) Impact of Untreated Obstructive Sleep Apnea on Glucose Control in Type 2 Diabetes. American Journal of Respiratory and Critical Care Medicine, 181, 507-513.
https://doi.org/10.1164/rccm.200909-1423OC
[13] Botros, N., Concato, J., Mohsenin, V., Selim, B., Doctor, K. and Yaggi, K. (2009) Obstructive Sleep Apnea as a Risk Factor for Type II Diabetes. American Journal of Medicine, 122, 1122-1127.
[14] Celen, Y.T., Hedner, J., Carlson, J. and Peker, Y. (2010) Impact of Gender on Incident Diabetes Mellitus in Obstructive Sleep Apnea: A 16-Year Follow-Up. Journal of Clinical Sleep Medicine: Official Publication of the American Academy of Sleep Medicine, 6, 244-250.
[15] Priou, P., Le Vaillant, M., Meslier, N., et al. (2015) Association between Obstructive Sleep Apnea Severity and Glucose Control in Patients with Untreated versus Treated Diabetes. Journal of Sleep Research, 24, 425-431.
https://doi.org/10.1111/jsr.12278
[16] Drager, L.F., Polotsky, V.Y. and Lorenzi-Filho, G. (2011) Obstructive Sleep Apnea: An Emerging Risk Factor for Atherosclerosis. Chest, 140, 534-542.
https://doi.org/10.1378/chest.10-2223
[17] Eisele, H., Markart, P. and Schulz, R. (2015) Obstructive Sleep Apnea, Oxidative Stress, and Cardiovascular Disease: Evidence from Human Studies. Oxidative Medicine and Cellular Longevity, 2015, Article ID: 608438.
[18] Rice, T.B., Foster, G.D., Sanders, M.H., et al. (2012) The Relationship between Obstructive Sleep Apnea and Self-Reported Stroke or Coronary Heart Disease in Overweight and Obese Adults with Type 2 Diabetes Mellitus. Sleep, 35, 1293-1298.
https://doi.org/10.5665/sleep.2090
[19] Leong, W.B., Nolen, M., Thomas, G.N., Adab, P., Banerjee, D. and Taheri, S. (2014) The Impact of Hypoxemia on Nephropathy in Extremely Obese Patients with Type 2 Diabetes Mellitus. Journal of Clinical Sleep Medicine, 10, 773- 778.
[20] Ozkok, A., Kanbay, A., Odabas, A.R., Covic, A. and Kanbay, M. (2014) Obstructive Sleep Apnea Syndrome and Chronic Kidney Disease: A New Cardiorenal Risk Factor. Clinical and Experimental Hypertension, 36, 211-216.
https://doi.org/10.3109/10641963.2013.804546
[21] Leong, W.B., Jadhakhan, F., Taheri, S., Thomas, G.N. and Adab, P. (2016) The Association between Obstructive Sleep Apnea on Diabetic Kidney Disease: A Systematic Review and Meta-Analysis. Sleep, 39, 301-308.
https://doi.org/10.5665/sleep.5432
[22] Tahrani, A.A., Ali, A., Raymond, N.T., et al. (2012) Obstructive Sleep Apnea and Diabetic Neuropathy: A Novel Association in Patients with Type 2 Diabetes. American Journal of Respira-tory and Critical Care Medicine, 186, 434-441.
https://doi.org/10.1164/rccm.201112-2135OC
[23] Tahrani, A.A., Ali, A., Raymond, N.T., et al. (2013) Obstruc-tive Sleep Apnea and Diabetic Nephropathy: A Cohort Study. Diabetes Care, 36, 3718-3725.
https://doi.org/10.2337/dc13-0450
[24] Baba, A., Zbiba, W., Bouayed, E., Korbi, M. and Ghrairi, H. (2016) Ob-structive Sleep Apnea Syndrome. Is It a Risk Factor for Diabetic Retinopathy? Journal Francais D Ophtalmologie, 39, 139-142.
[25] Louis, M. and Punjabi, N.M. (2009) Effects of Acute Intermittent Hypoxia on Glucose Metabolism in Awake Healthy Volunteers. Journal of Applied Physiology, 106, 1538-1544.
[26] Polak, J., Shimoda, L.A., Drager, L.F., et al. (2013) Intermittent Hypoxia Impairs Glucose Homeostasis in C57BL6/J Mice: Partial Improvement with Cessation of the Exposure. Sleep, 36, 1483-1490.
https://doi.org/10.5665/sleep.3040
[27] Lesser, D.J., Bhatia, R., Tran, W.H., et al. (2012) Sleep Fragmentation and Intermittent Hypoxemia Are Associated with Decreased Insulin Sensitivity in Obese Adolescent Latino Males. Pediatric Research, 72, 293-298.
https://doi.org/10.1038/pr.2012.73
[28] Cakmak, E., Duksal, F., Altinkaya, E., et al. (2015) Association between the Severity of Nocturnal Hypoxia in Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Damage. Hepatitis Monthly, 15, e32655.
https://doi.org/10.5812/hepatmon.32655
[29] Stamatakis, K.A. and Punjabi, N.M. (2010) Effects of Sleep Frag-mentation on Glucose Metabolism in Normal Subjects. Chest, 137, 95-101.
https://doi.org/10.1378/chest.09-0791
[30] Tasali, E., Leproult, R., Ehrmann, D.A. and Van Cauter, E. (2008) Slow-Wave Sleep and the Risk of Type 2 Diabetes in Humans. Proceedings of the National Academy of Sciences, 105, 1044-1049.
https://doi.org/10.1073/pnas.0706446105
[31] Pogach, M.S., Punjabi, N.M., Thomas, N. and Thomas, R.J. (2012) Electrocardiogram-Based Sleep Spectrogram Measures of Sleep Stability and Glucose Disposal in Sleep Disordered Breathing. Sleep, 35, 139-148.
https://doi.org/10.5665/sleep.1604
[32] Knutson, K.L., Van Cauter, E., Zee, P., Liu, K. and Lauderdale, D.S. (2011) Cross-Sectional Associations between Measures of Sleep and Markers of Glucose Metabolism among Subjects with and without Diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study. Diabetes Care, 34, 1171-1176.
https://doi.org/10.2337/dc10-1962
[33] Fang, Y., Zhang, Q., Tan, J., Li, L., An, X. and Lei, P. (2014) Intermittent Hypoxia-Induced Rat Pancreatic β-Cell Apoptosis and Protective Effects of Antioxidant Intervention. Nutrition & Di-abetes, 4, e131.
https://doi.org/10.1038/nutd.2014.28
[34] Xu, J., Long, Y., Gozal, D. and Epstein, P.N. (2009) Beta-Cell Death and Proliferation after Intermittent Hypoxia: Role of Oxidative Stress. Free Radical Biology & Medicine, 46, 783-790.
[35] Ota, H., Itaya-Hironaka, A., Yamauchi, A., et al. (2013) Pancreatic β Cell Proliferation by Intermittent Hypoxia via Up-Regulation of Reg Family Genes and HGF Gene. Life Sciences, 93, 664-672.
[36] Wang, N., Khan, S.A., Prabhakar, N.R. and Nanduri, J. (2013) Impaired Pancreatic Beta Cell Function by Chronic Intermittent Hypoxia. Experimental Physiology, 98, 1376-1385.
https://doi.org/10.1113/expphysiol.2013.072454
[37] Sherwani, S.I., Aldana, C., Usmani, S., et al. (2013) Intermittent Hypoxia Exacerbates Pancreatic β-Cell Dysfunction in a Mouse Model of Diabetes Mellitus. Sleep, 36, 1849-1858.
[38] Gu, C., Li, M., Li, Q. and Li, N. (2013) Chronic Intermittent Hypoxia Increases β Cell Mass and Activates the Mammalian Target of Rapamycin/Hypoxia Inducible Factor 1/Vascular Endothelial Growth Factor a Pathway in Mice Pancreatic Islet. Chinese Medical Journal, 126, 2368-2373.
[39] Wang, B., Yan, B., Song, D., Ye, X. and Liu, S.F. (2013) Chronic Intermittent Hypoxia Down-Regulates Endothelial Nitric Oxide Synthase Expression by an NF-κB-Dependent Mechanism. Sleep Medicine, 14, 165-171.
[40] Hirotsu, C., Albuquerque, R.G., Nogueira, H., et al. (2017) The Relationship between Sleep Apnea, Metabolic Dysfunction and Inflammation: The Gender Influence. Brain, Behavior, and Immunity, 59, 211-218.
[41] Archontogeorgis, K., Nena, E., Papanas, N. and Steiropoulos, P. (2014) Biomarkers to Improve Diagnosis and Monitoring of Obstructive Sleep Apnea Syndrome: Current Status and Future Perspectives. Pulmonary Medicine, 2014, Article ID: 930535.
[42] He, Q., Yang, Q.C., Zhou, Q., et al. (2014) Effects of Varying Degrees of Intermittent Hypoxia on Proinflammatory Cytokines and Adipokines in Rats and 3T3-L1 Adipocytes. PLoS ONE, 9, e86326.
https://doi.org/10.1371/journal.pone.0086326
[43] Vgontzas, A.N., Papanicolaou, D.A., Bixler, E.O., et al. (2000) Sleep Apnea and Daytime Sleepiness and Fatigue: Relation to Visceral Obesity, Insulin Resistance, and Hypercyto-kinemia. The Journal of Clinical Endocrinology & Metabolism, 85, 1151-1158.
https://doi.org/10.1210/jcem.85.3.6484
[44] Cheung, A.T., Ree, D., Kolls, J.K., Fuselier, J., Coy, D.H. and Bry-er-Ash, M. (1998) An in Vivo Model for Elucidation of the Mechanism of Tumor Necrosis Factor-Alpha (TNF-Alpha)-Induced Insulin Resistance: Evidence for Differential Regulation of Insulin Signaling by TNF-Alpha. Endocrinology, 139, 4928-4935.
[45] Svedberg, J., Björntorp, P., Smith, U. and Lönnroth, P. (1992) Effect of Free Fatty Acids on Insulin Receptor Binding and Tyrosine Kinase Activity in Hepatocytes Isolated from Lean and Obese Rats. Diabetes, 41, 294-298.
https://doi.org/10.2337/diab.41.3.294
[46] Hennes, M.M., Shrago, E. and Kissebah, A.H. (1990) Receptor and Postreceptor Effects of Free Fatty Acids (FFA) on Hepatocyte Insulin Dynamics. International Journal of Obesity, 14, 831-841.
[47] Agarwal, A., Hegde, A., Yadav, C., Ahmad, A., Manjrekar, P.A. and Srikantiah, R.M. (2017) Associa-tion of Interleukin-6 and Myeloperoxidase with Insulin Resistance in Impaired Fasting Glucose Subjects. Indian Journal of Clinical Biochemistry, 32, 33-38.
https://doi.org/10.1007/s12291-016-0567-8
[48] Kim, J.H., Bachmann, R.A. and Chen, J. (2009) Interleukin-6 and Insuanlin Resistence. Vitamins & Hormones, 80, 613-633.
[49] Pallayova, M., Steele, K.E., Magnuson, T.H., et al. (2010) Sleep Apnea Predicts Distinct Alterations in Glucose Homeostasis and Biomarkers in Obese Adults with Normal and Impaired Glucose Metabolism. Cardiovascular Diabetology, 9, 83.
https://doi.org/10.1186/1475-2840-9-83
[50] Pallayova, M., Lazurova, I. and Donic, V. (2011) Hypoxic Damage to Pancreatic Beta Cells—The Hidden Link between Sleep Apnea and Diabetes. Medical Hypotheses, 77, 930-934.
[51] Yang, J., Park, Y., Zhang, H., et al. (2009) Feed-Forward Signaling of TNF-Alpha and NF-Kappa B via IKK-Beta Pathway Contributes to Insulin Resistance and Coronary Arteriolar Dysfunction in Type 2 Diabetic Mice. American Journal of Physiology. Heart and Circulatory Physiology, 296, H1850-H1858.
https://doi.org/10.1152/ajpheart.01199.2008
[52] Gao, Z., Hwang, D., Bataille, F., et al. (2002) Serine Phosphor-ylation of Insulin Receptor Substrate 1 by Inhibitor Kappa B Kinase Complex. The Journal of Biological Chemistry, 277, 48115-48121.
https://doi.org/10.1074/jbc.M209459200
[53] Wu, X., Gu, W., Lu, H., et al. (2016) Soluble Receptor for Ad-vanced Glycation End Product Ameliorates Chronic Intermittent Hypoxia Induced Renal Injury, Inflammation, and Apoptosis via P38/JNK Signaling Pathways. Oxidative Medicine and Cellular Longevity, 2016, Article ID: 1015390.
[54] Wang, Y., Hai, B., Niu, X., et al. (2016) Chronic Intermittent Hypoxia Disturbs Insulin Secretion and Causes Pancreatic Injury via MAPK Signaling Pathway. Biochemistry and Cell Biology.
[55] Rosen, E.D. and Spie-gelman, B.M. (2006) Adipocytes as Regulators of Energy Balance and Glucose Homeostasis. Nature, 444, 847-853.
https://doi.org/10.1038/nature05483
[56] Bonsignore, M.R. and Eckel, J. (2009) ERS Meeting Report. Metabolic Aspects of Obstructive Sleep Apnoea Syndrome. European Respiratory Review, 18, 113-124.
https://doi.org/10.1183/09059180.00000109
[57] Kanbay, A., Kokturk, O., Ciftci, T.U., Tavil, Y. and Bukan, N. (2008) Comparison of Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels between Patients with and without Obstructive Sleep Apnea Syndrome. Respiration, 76, 324-330.
https://doi.org/10.1159/000134010
[58] Ryan, S. (2016) Adipose Tissue Inflammation by Intermittent Hypoxia: Mechanistic Link between Obstructive Sleep Apnoea and Metabolic Dysfunction. The Journal of Physiology.
[59] Fouillioux, C., Contreras, F., Lares, M., et al. (2008) Metabolic and Hemodynamic Markers of Endothelial Dysfunction in Patients with Hypertension and Patients with Type 2 Diabetes during the Cold Pressor Test. American Journal of Therapeutics, 15, 389-396.
https://doi.org/10.1097/MJT.0b013e318169bca8
[60] Hargens, T.A., Guill, S.G., Kaleth, A.S., et al. (2013) Insulin Resistance and Adipose-Derived Hormones in Young Men with Untreated Obstructive Sleep Apnea. Sleep Breath, 17, 403-409.
https://doi.org/10.1007/s11325-012-0708-0
[61] Arnardottir, E.S., Mackiewicz, M., Gislason, T., Teff, K.L. and Pack, A.I. (2009) Molecular Signatures of Obstructive Sleep Apnea in Adults: A Review and Perspective. Sleep, 32, 447-470.
[62] De Santis, S., Cambi, J., Tatti, P., Bellussi, L. and Passali, D. (2015) Changes in Ghrelin, Leptin and Pro-Inflammatory Cytokines after Therapy in Obstructive Sleep Apnea Syndrome (OSAS) Patients. Polish Journal of Otolaryngology, 69, 1-8.
https://doi.org/10.5604/00306657.1147029
[63] Lam, J.C.M., Mak, J.C.W. and Ip, M.S.M. (2012) Obesity, Obstructive Sleep Apnoea and Metabolic Syndrome. Respirology, 17, 223-236.
https://doi.org/10.1111/j.1440-1843.2011.02081.x
[64] Reinke, C., Bevans-Fonti, S., Drager, L.F., Shin, M. and Polotsky, V.Y. (2011) Effects of Different Acute Hypoxic Regimens on Tissue Oxygen Profiles and Metabolic Out-comes. Journal of Applied Physiology, 111, 881-890.
[65] Yang, R., Sikka, G., Larson, J., et al. (2011) Restoring Leptin Signaling Reduces Hyperlipidemia and Improves Vascular Stiffness Induced by Chronic Intermittent Hypoxia. American Journal of Physiology. Heart and Circulatory Physiology, 300, H1467-H1476.
https://doi.org/10.1152/ajpheart.00604.2009
[66] Li, J., Bosch-Marce, M., Nanayakkara, A., et al. (2006) Altered Metabolic Responses to Intermittent Hypoxia in Mice with Partial Deficiency of Hypoxia-Inducible Factor-Lalpha. Physiological Genomics, 25, 450-457.
https://doi.org/10.1152/physiolgenomics.00293.2005
[67] Zhang, X., Wang, Y., Li, Q., et al. (2010) Changes in Genioglossus and Their Association with Serum Adiponectin Levels in Rats Subjected to Chronic Intermittent Hypoxia. Chinese Medical Journal, 123, 2249-2253.
[68] Lam, D.C.L., Lam, K.S.L. and Ip, M.S.M. (2015) Obstructive Sleep Apnoea, Insulin Resistance and Adipocytokines. Clinical Endocrinology, 82, 165-177.
https://doi.org/10.1111/cen.12597
[69] Lam, J.C.M., Xu, A., Tam, S., et al. (2008) Hypoadiponectinemia Is Re-lated to Sympathetic Activation and Severity of Obstructive Sleep Apnea. Sleep, 31, 1721-1727.
https://doi.org/10.1093/sleep/31.12.1721
[70] De Lima, A.M.J., Franco, C.M.R., de Castro, C.M.M.B., et al. (2010) Effects of Nasal Continuous Positive Airway Pressure Treatment on Oxidative Stress and Adiponectin Levels in Obese Patients with Obstructive Sleep Apnea. Respiration, 79, 370-376.
https://doi.org/10.1159/000227800
[71] Wolk, R., Svatikova, A., Nelson, C.A., et al. (2005) Plasma Levels of Adiponectin, a Novel Adipocyte-Derived Hormone, in Sleep Apnea. Obesity Research, 13, 186-190.
https://doi.org/10.1038/oby.2005.24
[72] Gao, Z., He, Q., Peng, B., Chiao, P.J. and Ye, J. (2006) Regulation of Nuclear Translocation of HDAC3 by Ikappabalpha Is Required for Tumor Necrosis Factor Inhibition of Peroxisome Proliferator-Activated Receptor Gamma Function. The Journal of Biological Chemistry, 281, 4540-4547.
https://doi.org/10.1074/jbc.M507784200
[73] Yokoe, T., Alonso, L.C., Romano, L.C., et al. (2008) Intermittent Hypoxia Reverses the Diurnal Glucose Rhythm and Causes Pancreatic β-Cell Replication in Mice. The Journal of Physiology, 586, 899-911.
[74] Morton, N.M. (2010) Obesity and Corticosteroids: 11 Beta-Hydroxysteroid Type 1 as a Cause and Therapeutic Target in Metabolic Disease. Molecular and Cellular Endocrinology, 316, 154-164.
[75] Tamisier, R., Pépin, J.L., Rémy, J., et al. (2011) 14 Nights of Intermittent Hypoxia Elevate Daytime Blood Pressure and Sympathetic Activity in Healthy Humans. European Respiratory Journal, 37, 119-128.
https://doi.org/10.1183/09031936.00204209
[76] Prabhakar, N.R., Kumar, G.K. and Peng, Y. (2012) Sympa-tho-Adrenal Activation by Chronic Intermittent Hypoxia. Journal of Applied Physiology, 113, 1304-1310.
[77] Kline, C.E., Reboussin, D.M., Foster, G.D., et al. (2016) The Effect of Changes in Cardiorespiratory Fitness and Weight on Obstructive Sleep Apnea Severity in Overweight Adults with Type 2 Diabetes. Sleep, 39, 317-325.
https://doi.org/10.5665/sleep.5436
[78] Kuna, S.T., Reboussin, D.M., Borradaile, K.E., et al. (2013) Long-Term Effect of Weight Loss on Obstructive Sleep Apnea Severity in Obese Patients with Type 2 Diabetes. Sleep, 36, 641-649.
https://doi.org/10.5665/sleep.2618
[79] Pamidi, S., Wroblewski, K., Stepien, M., et al. (2015) Eight Hours of Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Improves Glucose Metabolism in Patients with Prediabetes. A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine, 192, 96-105.
https://doi.org/10.1164/rccm.201408-1564OC
[80] Weinstock, T.G., Wang, X., Rueschman, M., et al. (2012) A Controlled Trial of CPAP Therapy on Metabolic Control in Individuals with Impaired Glucose Tolerance and Sleep Apnea. Sleep, 35, 617-625.
https://doi.org/10.5665/sleep.1816
[81] Guo, L., Zhao, X., Pan, Q., et al. (2015) Effect of Continuous Positive Airway Pressure Therapy on Glycemic Excursions and Insulin Sensitivity in Patients with Obstructive Sleep Ap-nea-Hypopnea Syndrome and Type 2 Diabetes. Chinese Medical Journal, 128, 2301-2306.
https://doi.org/10.4103/0366-6999.163382
[82] Salord, N., Fortuna, A.M., Monasterio, C., et al. (2016) A Ran-domized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Ob-structive Sleep Apnea. Sleep, 39, 35-41.
https://doi.org/10.5665/sleep.5312
[83] Iftikhar, I.H., Khan,M.F., Das, A. and Magalang, U.J. (2013) Me-ta-Analysis: Continuous Positive Airway Pressure Improves Insulin Resistance in Patients with Sleep Apnea without Diabetes. Annals of the American Thoracic Society, 10, 115-120.
https://doi.org/10.1513/AnnalsATS.201209-081OC
[84] Guest, J.F., Panca, M., Sladkevicius, E., Taheri, S. and Stradling, J. (2014) Clinical Outcomes and Cost-Effectiveness of Continuous Positive Airway Pressure to Manage Ob-structive Sleep Apnea in Patients with Type 2 Diabetes in the U.K. Diabetes Care, 37, 1263-1271.
https://doi.org/10.2337/dc13-2539
[85] Prasad, B., Carley, D.W., Krishnan, J.A., Weaver, T.E. and Weaver, F.M. (2012) Effects of Positive Airway Pressure Treatment on Clinical Measures of Hypertension and Type 2 Diabetes. Journal of Clinical Sleep Medicine, 8, 481-487.
https://doi.org/10.5664/jcsm.2136
[86] Plíhalová, A., Westlake, K. and Polák, J. (2016) Obstructive Sleep Apnoea and Type 2 Diabetes Mellitus. Vnitrní Lékarství, 62, 79-84.